1. Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review.
- Author
-
Sellés EG, Pieretti DG, Higuero PP, Del Portillo EG, Macías VM, Domínguez MM, Mateos RF, Campos FL, Díaz-Gavela AA, Ferraris G, and Couñago F
- Subjects
- Humans, Neoadjuvant Therapy, Chemoradiotherapy, Chemotherapy, Adjuvant, Neoplasms, Second Primary, Rectal Neoplasms
- Abstract
Locally advanced rectal cancer has traditionally been treated with chemoradiotherapy (CRT) followed by surgery and adjuvant chemotherapy. However, a new strategy, total neoadjuvant therapy, involves the administration of CRT and neoadjuvant chemotherapy with the aim of eradicating micrometastases earlier and achieving greater control of the disease. The use of total neoadjuvant therapy has shown higher rates of pathological complete response and resectability compared with CRT, including improved survival. Nevertheless, distant relapse is the main cause of morbidity and mortality in locally advanced rectal cancer. To address this, new biomarkers are being developed to predict disease response.
- Published
- 2023
- Full Text
- View/download PDF